Navigation Links
Boehringer Ingelheim's Investigational Therapy Nintedanib Receives FDA Breakthrough Therapy Designation
Date:7/16/2014

RIDGEFIELD, Conn., July 16, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough Therapy designation to nintedanib, an investigational therapy currently under FDA review for the treatment of people with idiopathic pulmonary fibrosis (IPF). The efficacy and safety of nintedanib in the treatment of IPF has not been established.

"Boehringer Ingelheim is proud that the FDA has granted Breakthrough Therapy designation for nintedanib, which will help expedite its development and review as a potential treatment option for patients with IPF," said Sabine Luik, M.D., senior vice president, Medicine & Regulatory Affairs at Boehringer Ingelheim Pharmaceuticals, Inc. "We are committed to working with the FDA during the NDA review of nintedanib for people living with this serious and life-threatening lung disease, for which there are currently no FDA-approved treatment options."

The Breakthrough Therapy designation process was established by the FDA in 2012 and is intended to expedite the development and review of drugs for serious or life-threatening conditions, and preliminary clinical evidence indicates that the therapy may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints.

IPF is a serious and life-threatening lung disease that causes permanent scarring of the lungs, difficulty breathing and decreases the amount of oxygen the lungs can supply to the body. IPF affects as many as 132,000 Americans. There are currently no FDA-approved treatments.

Results from two global Phase 3 studies (INPULSIS™-1 and INPULSIS™-2) evaluating the efficacy and safety of nintedanib in the treatment of IPF were presented at the American Thoracic Society (ATS) International Conference and published in the New England Journal of Medicine in May 2014.

'/>"/>
SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Circuit Therapeutics and Boehringer Ingelheim announce signature of a research partnership agreement to discover new approaches to treating psychiatric disorders
2. Apollo Medical Holdings and Boehringer Ingelheim to Collaborate On Care of ApolloMed Accountable Care Organization (ACO) Patients with COPD
3. Largest Global Survey Investigating Early Type 2 Diabetes Conversations Launched by Boehringer Ingelheim and Eli Lilly and Company in Partnership with the International Diabetes Federation
4. Boehringer Ingelheims Jeff Huth Elected as National Pharmaceutical Councils Chairman of the Board
5. Boehringer Ingelheims interferon-free hepatitis C treatment portfolio strengthened by promising interim Phase 2a data
6. Pivotal Phase 3 Data from Boehringer Ingelheim Hepatitis C Portfolio to be Presented at 64th Annual AASLD Meeting
7. Boehringer Ingelheim Pharmaceuticals, Inc. colabora con Univision Communications Inc. para lanzar una campaña integrada en español
8. Boehringer Ingelheim Pharmaceuticals, Inc. Collaborates With Univision Communications Inc. To Launch An Integrated Campaign In Spanish
9. Boehringer Ingelheims investigational volasertib receives FDA Breakthrough Therapy designation
10. Boehringer Ingelheim Expands Investigation of Interferon-free Hepatitis C Treatment Regimens to Reach More Patient Types through Presidio Pharmaceuticals Clinical Collaboration
11. Boehringer Ingelheim Pharmaceuticals, Inc. Statement on RE-ALIGN Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 2014 BRIC Gynecological Devices Market Outlook ... GlobalData,s new report, "BRIC Gynecological Devices Market Outlook ... BRIC Gynecological Devices market. The report provides value, ... and average prices (in US dollars) within market ... (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and ...
(Date:9/17/2014)... 17, 2014 The ambulance equipment ... decade due to the recession, an unstable ... advancements. This BCC Research report analyzes present ... the ambulance and emergency medical services equipment ... hemorrhage control devices, equipment used for burn ...
(Date:9/17/2014)... Pomerantz LLP is investigating claims on behalf ... the "Company") (NASDAQ: PDLI).  Such investors are advised to ... or 888-476-6529, ext. 237. The investigation ... and/or directors have violated Sections 10(b) and 20(a) of ... On September 17, 2014, the Company announced that On ...
Breaking Medicine Technology:BRIC Gynecological Devices Market Outlook to 2020 2BRIC Gynecological Devices Market Outlook to 2020 3Ambulance and Emergency Equipment: Global Markets 2Ambulance and Emergency Equipment: Global Markets 3Ambulance and Emergency Equipment: Global Markets 4SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PDL BioPharma, Inc. - PDLI 2
... 2012 Synteract , Inc., a full-service contract ... developing new therapies to combat the growing issue of ... Great Strides fundraising walk to benefit the Cystic ... Rempex (on behalf of Aptalis Pharma) are also working ...
... Ind., May 2, 2012  Hill-Rom Holdings, Inc. (NYSE: ... declared a fiscal year 2012 third quarter dividend of $0.125 ... to shareholders of record as of the close of business ... HOLDINGS, INC. Hill-Rom is a leading worldwide manufacturer ...
Cached Medicine Technology:Synteract and Rempex Partner in "Great Strides" Walk to Support Cystic Fibrosis Cure 2
(Date:9/17/2014)... -- Positive messages about the health benefits of quitting ... new study suggests. Although smokers who think quitting ... the harmful effects of smoking, researchers found smokers who ... from "gain-framed," or positive, messages about how quitting will ... a mix of both types of messages might get ...
(Date:9/17/2014)... [Brown University] As Congress adjourns this month for ... will step over on their way out the chamber ... and Medicare Provider Payment Modernization Act of 2014. In ... , Dr. Eli Adashi recounts what he and other ... bill. The perennial trouble with how Medicare pays doctors ...
(Date:9/17/2014)... New York (PRWEB) September 17, 2014 ... involving the Conserve line of metal-on-metal hip replacements ... underway in U.S. District Court, Northern District of ... updated Case List issued by the U.S. Judicial ... at least 397 product liability claims have been ...
(Date:9/17/2014)... Boston Children’s Museum and From ... concert series, introducing young Museum visitors to musicians ... premier national platform celebrating the stories, talents, and ... young musicians featured will also be showcased on ... is fortunate to partner with the wonderful musicians ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Smart Flour ... Picks by Progressive Grocer, a leading trade magazine targeted ... awarded for originality and flavor, among other attributes. Smart ... an Editor’s Pick in the September print issue of ... website. , The pizza won based on its superior ...
Breaking Medicine News(10 mins):Health News:More Than One Kind of Message May Convince Smokers to Quit, Study Says 2Health News:Failed Medicare payments law remains relevant 2Health News:Failed Medicare payments law remains relevant 3Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 2Health News:Wright Hip Lawsuit News: Nearly 400 Filings Reported in Federal Wright Conserve Hip Replacement Litigation, Bernstein Liebhard LLP Reports 3Health News:Boston Children's Museum Partners with From the Top to Offer Monthly Concert Series 2Health News:Boston Children's Museum Partners with From the Top to Offer Monthly Concert Series 3Health News:Smart Flour Foods Wins 2014 Progressive Grocer Editor’s Pick Award 2
... step is compromise with House plan, before proposal can become ... gave President Barack Obama a Christmas Eve gift on Thursday ... extend coverage to 31 million uninsured Americans. , Obama said ... that he has sought since his inauguration on Jan. 20. ...
... ... deliver point-of-care drug information on Android devices, , ... Hudson, OH (PRWEB) December 24, 2009 ... healthcare professionals, has released an application for Google Android devices. This latest ...
... ... a distributor of new-to-market nutraceutical and functional food ingredients and ... Purple Stuff, has announced that LuraLean®, AHD’s condensed, water-soluble, dietary ... levels already within the normal range and support regularity, is ...
... , Children,s National Posts Favorite Story on Its Site ... the holiday classic ,Twas the Night before Christmas by ... Center. A video of the classic story being read by ... website, so children and families around the country and world can ...
... , , MINNEAPOLIS, Dec. 23 ... Year,s resolutions for many Minnesotans. As the holiday approaches, ... Minnesota(SM), hopes to motivate them to make a fresh ... most smokers resolve to quit. The new ad acknowledges ...
... , ATLANTA, Dec. 23 At ... of corporate citizenship by fulfilling our mission to offer ... products, unsurpassed quality and service standards, and creative solutions. ... the communities where we do business, we embrace opportunities ...
Cached Medicine News:Health News:Senate Passes Health Reform Package 2Health News:Senate Passes Health Reform Package 3Health News:Senate Passes Health Reform Package 4Health News:Lexi-Comp Now Available for Android™ 2Health News:AHD International & Funktional Beverages, Inc Launch Red Stuff™ with LuraLean 2Health News:'Twas the Night Before Christmas: First Lady Michelle Obama Reads the Holiday Classic 2Health News:Smokers: Resolve to Get the Monkey off Your Back in 2010 2Health News:Smokers: Resolve to Get the Monkey off Your Back in 2010 3Health News:Angelica Extends Helping Hand to Haitian Hospital 2
... line of Surgical Microscope Accessories includes ... lenses, fiber optic cables, and fiberoptic ... Adaptor attaches directly to a Zeiss® ... used to mount the Photo Adaptor ...
Inquire...
... Femoral Compression System consists of a ... FemoStop Femoral Compression System.,Both devices work ... Hemostatic Dressing achieves topical hemostasis by ... while FemoStop Femoral Compression System provides ...
... system. It stores patient chart notes, x-rays, laboratory ... would normally put in a file folder. Your ... write them, file them, find them, determine billing ... lost. They find their way to your house ...
Medicine Products: